Veraxa Biotech appointed Raju Willener as CFO effective immediately on September 4, 2026, naming him principal financial and accounting officer after experience overseeing portfolios exceeding CHF 30 billion. The appointment matters because he is tasked with strengthening Capital strategy, disciplined capital allocation and strategic opportunities as the oncology pipeline advances.

Key Highlights

  • Veraxa Biotech appointed Raju Willener as chief financial officer effective immediately on September 4, 2026.
  • Willener will serve as the company’s principal financial officer and principal accounting officer.
  • Before joining Veraxa, he served as Exentis Group AG’s director of corporate development and became its chief financial officer in 2025.

Veraxa Biotech AG - Post de-SPAC (NASDAQ: VRXA) appointed Raju Willener as chief financial officer effective immediately on September 4, 2026. He will serve as the company’s principal financial officer and principal accounting officer, reporting to Chief Executive Officer and Co-Founder Christoph Antz, Ph.D. Willener brings international capital-markets and corporate-finance experience to Veraxa.

Willener Takes Principal Finance Role

Willener previously worked at Exentis Group AG as director of corporate development before becoming its chief financial officer in 2025. His responsibilities there included mergers and acquisitions, financial strategy and key corporate functions. Carl von Halem is identified as Veraxa’s former CFO.

Capital Strategy Tied to Oncology Pipeline

Veraxa said Willener will support its BiTAC platform and oncology pipeline by helping strengthen capital strategy, assess strategic opportunities and maintain disciplined execution. The announcement also says he will support disciplined capital allocation and pursue opportunities that can accelerate development of the pipeline. Willener said he would work with Antz and the Leadership team on financial and capital-markets strategy. The company also linked the role to long-term value creation for shareholders.